Rheumatology has made many breakthroughs in China in recent years, and consensus and standard updates have been introduced every year in clinical diagnosis and treatment. Most rheumatic diseases are chronic diseases, and their prognosis depends not only on diagnosis and treatment, but also on the continuous and long-term management after diagnosis and treatment.

In order to further improve the regional level of rheumatic and immune disease diagnosis and treatment, and to strengthen the understanding of rheumatic and immune diseases among physicians at all levels, Chengdu Hi-Tech Medical Association will hold an online meeting on March 15, 2024 for the exchange of rheumatic and immune disease diagnosis and treatment. The meeting will invite domestic experts in rheumatic and immune diseases and related fields to give lectures and discuss and exchange classical cases and cutting-edge technologies in related specialties.